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Summary  Microsporidia  cause  diarrhea  among  human  immunodeﬁciency  virus
(HIV)  infected  patients  worldwide.  Enterocytozoon  bieneusi  and  Encephalitozoon
intestinalis  are  the  most  common  species  infecting  HIV  patients.  Various  genotypes
of  E.  bieneusi  are  transmitted  from  human  to  human  (anthroponotic  route)  or  from
animal  to  human  (zoonotic  route).  However,  there  is  no  study  from  India  on  geno-
types  of  E.  bieneusi  among  infected  hosts.  Therefore,  we  aimed  to  (a)  study  the
prevalence,  clinical  symptoms,  and  species  identiﬁcation  of  microsporidia  among
HIV  infected  patients  and  (b)  perform  a  genotypic  analysis  of  E.  bieneusi  and  a  phy-
logenetic  interpretation  of  the  transmission  of  different  genotypes  among  infected
hosts.  Two  hundred  and  twenty-two  HIV-infected  patients  and  220  healthy  controls
(HC)  were  tested  for  the  presence  of  microsporidia  using  modiﬁed  trichrome  (MT)
staining  and  PCR.  Demographic,  clinical  and  laboratory  parameters  were  studied.
Species  identiﬁcation  was  performed  using  PCR-RFLP.  All  E.  bieneusi  isolates  were
subjected  to  genotypic  and  phylogenetic  analysis.  Patients  with  HIV  [n  =  222,  age
37.4  ±  10.4  y,  169  (76%)  male]  were  more  commonly  infected  with  microsporidia
than  the  HC  [n  =  220,  age  34.5  ±  6.5  y,  156  (71%)  male],  using  MT  stain  and  PCR
[4/222,  1.8%  vs.  0/220,  p  =  0.04].  Patients  infected  with  microsporidia  more  com-
monly  presented  with  diarrhea  than  those  not  infected  with  microsporidia  [4,
100%  vs.  98/218,  45%;  p  =  0.04].  E.  bieneusi  was  detected  in  all  patients  with
microsporidia.  Four  novel  genotypes  (Ind1  to  Ind4)  were  identiﬁed.  Ind1  showed  95%
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Introduction
Microsporidia  commonly  cause  intestinal
microsporidiosis  among  HIV-infected  patients
worldwide, with  a  prevalence  ranging  from  0.1%  to
50% [1].  It  is  still  under-reported  in  HIV  patients
from a  developing  country  such  as  India,  with  a
prevalence  ranging  from  1%  to  15.9%  [2—5]. Diar-
rhea is  the  most  common  clinical  manifestation  of
intestinal microsporidiosis  among  HIV  patients  with
CD4 cell  counts  ≤100  cells/l  [6,7].
Enterocytozoon  bieneusi  (E.  bieneusi)  and
Encephalitozoon intestinalis  are  the  most
common species  of  microsporidia  causing  intesti-
nal microsporidiosis  in  humans  [5].  Intestinal
microsporidiosis  caused  by  Encephalitozoon  hellem
has been  diagnosed  in  very  few  cancer  patients
[8].  E.  bieneusi,  the  most  common  species,  is
often associated  with  chronic  diarrhea  in  patients
infected with  HIV  [6].  The  drug  of  choice,  alben-
dazole, is  not  very  effective  against  E.  bieneusi.
Therefore, emphasizing  strategies  to  prevent  infec-
tion in  humans  would  be  useful.  The  establishment
of preventive  measures  depends  upon  tracing
the route  of  transmission.  Spores  of  E.  bieneusi
infecting humans,  animals  and  birds  are  shed  in
the host’s  feces.  Therefore,  the  transmission  route
may be  person  to  person  (anthroponotic)  or  animal
to human  (zoonotic).  Genotyping  of  E.  bieneusi
isolates is  a  valuable  tool  for  epidemiological
investigations  [9]. The  genotyping  is  widely  based
on analysis  of  an  internal  transcribed  spacer  (ITS)
of rRNA  genes  of  microsporidia.  To  date,  approx-
imately 90  genotypes  of  E.  bieneusi  infecting
humans and  animals  have  been  identiﬁed  [10].
Some of  the  genotypes  are  host  speciﬁc,  infecting
only humans,  while  others  can  infect  humans  as
well as  animals  and  thereby  have  zoonotic  poten-
tial [11].  E.  bieneusi  is  the  most  common  species
infecting animals  and  humans.  Its  transmission
route among  humans  is  still  unclear  in  a devel-
oping nation  such  as  India.  To  date,  no  study  has
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F267142.1)  reported  in  cats  (Germany).  Genotypes  Ind2
arity  to  host-speciﬁc  genotype  A  (AF101197.1)  reported
alysis  mainly  showed  an  anthroponotic  route  of  trans-
notic  route  (1/4)  was  also  observed.  The  prevalence  of
cted  patients  was  1.8%.  Patients  with  microsporidia  com-
.  E.  bieneusi  is  the  most  common  species  infecting  the
l  genotypes  of  E.  bieneusi  were  identiﬁed,  suggesting
inly  through  the  anthropological  route.
 Limited  on  behalf  of  King  Saud  Bin  Abdulaziz  University
een  reported  on  genotypes  of  E.  bieneusi  among
IV-infected  patients  in  India.  Understanding  the
olecular epidemiology  of  E.  bieneusi,  including
he route  of  transmission,  would  help  to  establish
revention strategies  in  India.
Accordingly,  we  aimed  to  (a)  study  the  preva-
ence, clinical  symptoms  and  species  identiﬁcation
f microsporidia  among  HIV-infected  patients  and
b) perform  genotypic  analysis  of  E.  bieneusi  and
hylogenetic  interpretation  of  the  transmission  of
ifferent genotypes  among  infected  hosts.
ethods
tudy population and protocol
wo  hundred  and  twenty-two  consecutive  HIV-
nfected patients  (with  and  without  diarrhea)
ttending the  Immunology  unit  of  a tertiary
are institution  were  tested  for  the  presence  of
icrosporidia  during  March  2010  to  November  2014.
atients infected  with  HIV  were  included  in  the
tudy as  per  National  AIDS  Control  Organization
NACO) guidelines  [12]. Patients  without  HIV  infec-
ion were  excluded.  Two  hundred  and  twenty  age-
nd sex-matched  healthy  controls  without  any  his-
ory of  apparent  illness  within  the  last  4  weeks  were
ncluded  in  the  study.  Data  on  demographic,  clini-
al and  laboratory  parameters  were  recorded  in  a
tandard questionnaire  for  each  patient.  Patients
ere asked  if  they  purify  potable  water  (ﬁltered
ater) or consume  the  potable  water  without  any
uriﬁcation  (unﬁltered  water).  The  study  protocol
as approved  by  the  Institutional  Ethics  Committee
PGI/DIR/RC/1085/2007).
ample collectionhree  consecutive  fresh  stool  samples  were  col-
ected from  each  patient  and  healthy  control.  The
amples  were  subjected  to  routine  stool  microscopy



























































































Senotyping  of  Enterocytozoon  bieneusi  among  hum
normal  saline  and  iodine),  and  a  part  was  stored
t −40 ◦C  in  normal  saline  for  deoxyribose  nucleic
cid (DNA)  extraction.  Blood  samples  were  also
ollected  in  an  ethylene  diamine  tetraacetic  acid
EDTA) vial  for  CD4  count.
ample processing
tool  samples  were  subjected  to  the  formalin  ether
oncentration  technique.  Thereafter,  smears  were
ade from  the  deposit  and  air-dried.  These  smears
ere stained  using  Weber’s  modiﬁed  trichrome
tain with  certain  modiﬁcations  [13].  Brieﬂy,  fast
reen was  used  as  a  counter-stain,  and  a  smear
as incubated  in  trichrome  stain  at  50 ◦C  for
0—12 min.  The  smears  were  observed  under  a  light
icroscope.  CD4+  cells  were  counted  using  Becton
ickinson (BD)  ﬂuorescence-activated  cell  sorting
FACS) ﬂow  CD4/CD3  reagent  kit  (BD  Biosciences,
A, USA).
pecies identiﬁcation
hree  consecutive  stool  samples  collected  from
ach patient  and  healthy  control  were  pooled  into
ne aliquot  each.  DNA  was  extracted  from  the
ooled stool  samples  using  a  QIAamp  Qiagen  mini
tool kit  (Qiagen  Inc.,  Valencia,  CA,  USA)  accord-
ng to  the  manufacturer’s  instructions  with  some
odiﬁcations.  Brieﬂy,  the  sample  was  suspended
n phosphate-buffered  saline  (PBS)  and  subjected
o centrifugation.  The  suspension  was  heated  at
0 ◦C  for  10  min.  The  extracted  fecal  DNA  was  sub-
ected  to  ampliﬁcation  of  the  conserved  region
f a  small  subunit  of  the  rRNA  (SSU  rRNA)  gene
f microsporidia  using  a  previously  published  for-
ard primer  C1  (5′-CACCAGGTTGATTCTGCC-3′) and
everse primer  C2  (5′-GTGACGGGCGGTGTGTAC-3′)
nd polymerase  chain  reaction  (PCR)  cycle  condi-
ions [14].
The ampliﬁed  fragments  were  subjected  to
igestion using  the  restriction  endonucleases  HinfI
nd HindIII  to  differentiate  among  four  human
icrosporidia species,  namely,  E.  bieneusi,  E.
ntestinalis, E.  cuniculi  and  E.  hellem  [14].
etection criteriaetection  of  spores  of  microsporidia  using
icroscopy in  one  or  more  stool  samples  or
ts DNA  during  molecular  analysis  indicated  that
he sample  was  positive  for  microsporidia.
D
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enotyping of E. bieneusi
enotyping  of  E.  bieneusi  was  performed  through
ucleotide sequence  analysis  of  the  ITS  region
f the  rRNA  gene.  To  amplify  the  ITS  region  of
he rRNA  gene,  two-step  nested  PCR  was  per-
ormed. For  the  primary  PCR,  a PCR  product
f 410  bp  was  ampliﬁed  using  primers  AL4037  5′
ATGGTCATAGGGATGAAGAGCTT  3′ and  AL4039  5′
CGGATCCAAGTGATCCTGTATT  3′. The  PCR  mix-
ure consisted  of  1  or  2  l  of  DNA,  200  M  (each)
eoxynucleoside  triphosphates,  1×  PCR  buffer
Perkin-Elmer, Foster  City,  CA),  3.0  mM  MgCl2, 5.0  U
f Taq  polymerase  (GIBCO  BRL,  Frederick,  MD)  and
00 nM  (each)  primers  in  a  total  of 100  l of  reac-
ion mixture.  The  reactions  were  performed  for  35
ycles (94 ◦C  for  45  s,  55 ◦C  for  45  s and  72 ◦C  for
0 s)  with  an  initial  hot  start  (94 ◦C  for  3  min)  and  a
nal extension  (72 ◦C  for  10  min).  For  the  secondary
CR, a fragment  of 392  bp  was  ampliﬁed  using
.5 l  of  primary  PCR  product  and  primers  AL4038
′ AGGGATGAAGAGCTTCGGCTCTG  3′ and  AL4040
′ AGTGATCCTGTATTAGGGATATT  3′. The  conditions
or secondary  PCR  were  identical  to  those  of  pri-
ary  PCR  [15].
equencing
uriﬁed  PCR  products  were  sequenced  by  com-
ercially available  sequencing  services,  Bangalore
enei,  Bangalore,  India  using  E.  bieneusi  speciﬁc
TS sequence  forward  primer.  Electropherograms
ere analyzed  and  aligned  with  previously  reported
TS sequences  of  E.  bieneusi  using  standard  soft-
are (Chromas  program,  Technelysium  Pvt.  Ltd.,
ydney, Australia  and  Bio  Edit  v 7.0.5,  Ibis  Bio-
ciences,  Carlsbad,  California,  respectively).  Iden-
iﬁed sequences  were  submitted  to  the  National
enter for  Biotechnology  Information  (NCBI).
hylogenetic analysis
.  bieneusi  ITS  sequences  were  determined,
nd a multiple  alignment  was  performed  using
he ClustalW  program  (http://www.clustal.org/).
hylogenetic analysis  was  performed  using  the
EGA 5.0  program  employing  a distance  matrix
nd a maximum-likelihood  parameter.  A  neighbor
oining  tree  was  generated  using  the  Kimura  two-
arameter  model.
tatistical analysisata  were  checked  for  normal  distribution  using
he Kolmogorov—Smirnov  test.  Categorical,  para-
etric  and  non-parametric  continuous  data  were
S.  Khanduja  et  al.
Fig.  1  Spores  of  microsporidia  in  a  stool  sample  of








presented  as  proportion,  mean,  standard  devia-
tion,  median  and  inter-quartile  range,  respectively.
Chi-square, Fisher’s  exact,  and  Mann—Whitney  U
tests were  used  to  compare  between  categorical,
continuous parametric  and  non-parametric  data,
respectively.  P  values  below  0.05  were  considered
signiﬁcant for  all  statistical  analysis.  Statistical
analysis was  performed  using  SPSS  version  15  (SPSS,
Inc., Chicago,  IL,  USA).
Results
Study population
A  total  of  660  stool  samples  were  collected  from
222 HIV-infected  patients.  Of  the  222  HIV-infected
patients, 169/222  (76%)  were  male,  with  a mean
age of  37.4  ±  10.4  y.  Of  the  220  healthy  controls,
156/220 (71%)  were  male,  with  a  mean  age  of
34.5 ±  6.5  y.
Detection of microsporidia among
HIV-infected  patients and controlsFour  of  222  (1.8%)  HIV-infected  patients  and
none of  the  healthy  controls  had  microsporidia






Table  1  Demographic,  clinical  and  laboratory  parameters
HIV  infected  patients.
Microsporidia  pres
Age  (mean,  SD)  36  (5.4)  
Gender  (male)  4 (100%)  
Diarrhea  4 (100%)  
Type  of  diarrheaa
Acute  2/4  (50%)  
Persistent  1/4  (25%)  
Chronic  1/4  (25%)  
Daily  stool  frequency  (median,  IQR)  4 (2.5,  4)  
Stool  character  (watery)  2 (50%)  
CD4  count
<200  cells/l 4/4  
200—500  cells/l 0 
>500  cells/l 0 
Fever  2/4  (50%)  
Cough  2/4  (50%)  
Contact  with  animalsb 2/4  (50%)  
Type  of  drinking  waterb
Unﬁltered  water  4 (100%)  
a Type of diarrhea (n = 102).
b Data on contact with animals and type of drinking water availa light  microscope.  The  arrow  represents  the  spores  of
icrosporidia.
actors associated with the occurrence of
icrosporidia among HIV-infected patients
able  1 shows  the  factors  associated  with  the
ccurrence of  microsporidia  among  HIV-infected
atients. All  patients  infected  with  microsporidia
ere male,  with  a mean  age  of  36  ±  5.4  y.  Diar-
hea was  more  prevalent  among  patients  infected
ith microsporidia  than  those  without  (4/4,  100%
s. 98/218,  45%;  p =  0.04).  Data  on  the  type  of
 of  patients  with  and  without  microsporidiosis  among
ent  (n  =  4)  No  microsporidia  (n  =  218)  p-Value
37.5  (10.5)  0.86
165/218  (75.7%)  0.25
98/218  (45%)  0.04
32/98  (32.7%)  0.5
22/98  (22.4%)  0.9
45/98  (46%)  0.4
2  (2,4)  0.3




124/218  (56.9%)  1.0
72/218  (33%)  0.6
2/93  (2.1%)  0.3
0/93  0.04
ble in 97 patients only.
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Fig.  2  (a)  An  agarose  gel  showing  PCR  products  of  human  fecal  samples  positive  for  microsporidia.  Lane  M,  50  bp
ladder;  Lane  PC,  positive  control  for  microsporidia;  Lanes  1—3,  microsporidia-positive  samples;  Lane  NC,  negative
control.  (b)  Digestion  pattern  of  PCR  products  using  the  restriction  enzymes  HinfI  and  Hind  III.  Lane  M,  100  bp  ladder;






















p,  samples  positive  for  E.  bieneusi  using  HinfI.
rinking  water  and  contact  with  animals  were
vailable for  97  patients.  All  patients  infected
ith microsporidia  had  unﬁltered  water  (4/4,
00% vs.  0/93;  p  =  0.04).  Other  clinical  manifes-
ations including  fever,  cough,  headache,  chest
ain, watery  stool  and  contact  with  animals  were
omparable  among  patients  with  and  without
icrosporidia. All  four  infected  patients  had  a  CD4
ount <100  cells/l.  Among  them,  two  patients  had
D4 cell  counts  ≤100  cells/l,  while  two  had  CD4
ounts  ≤50  cells/l.
i
b
ig.  3  An  agarose  gel  showing  secondary  PCR  ampliﬁed  pro
ositive  control  of  ITS  of  E.  bieneusi;  Lanes  1—3,  samples  ampecies identiﬁcation
 1200  bp  ampliﬁed  fragment  of  microsporidia  was
bserved  using  the  speciﬁed  primers  (Fig.  2a).
he ampliﬁed  product  was  subjected  to  enzymatic
igestion  using  the  restriction  enzymes  HinfI  and
indIII and  displayed  one  restriction  site  with  two
ands of  230  bp,  940  bp  and  386  bp,  784  bp,  respec-
ively (Fig.  2b).  This  pattern  of  bands  suggests
nfection with  E.  bieneusi, which  was  conﬁrmed
y sequencing  of  PCR  products  in  all  patients.
ducts  of  ITS  of  E.  bieneusi.  Lane  M,  100  bp  ladder;  PC,
pliﬁed  for  ITS  of  E.  bieneusi;  NC,  negative  control.
36  S.  Khanduja  et  al.
Table  2  Polymorphic  sites  in  the  ITS  of  E.  bieneusi  genotypes  L  (consensus),  Ind1,  A  (consensus),  Ind2,  Ind3  and
Ind4.
Genotype  Nucleotide  positions  in  ITS  of  E.  bieneusi
5th  37th  73rd  135th  167th  228th  338th  339th
L  consensus A  T  G  A  A  T  C  T
Ind1  -  ·  A  C  ·  ·  ·  A
A  consensus  A  T  G  T  A  T  A  T
Ind2  -  -  ·  ·  T  ·  ·  A
Ind3  -  ·  ·  ·  ·  - ·  A




































a· Represents same base pair as that of consensus sequence; - r
E.  intestinalis, E.  hellem  and  E.  cuniculi  were  not
detected  in  any  patient.
Genotyping of E. bieneusi
ITS  sequences  of  E.  bieneusi  were  ampliﬁed  in
the four  patients  (Fig.  3).  E.  bieneusi  belonged  to
four distinct  novel  genotypes  (Ind1  to  Ind4).  The
four novel  genotypes  differed  from  each  other  by
various  single  nucleotide  polymorphisms  in  their
ITS sequences.  Genotype  Ind1  showed  95%  simi-
larity with  genotype  L  (AF267142.1)  reported  in
cats from  Germany  with  nucleotide  changes  at
four positions  (Table  2).  Genotypes  Ind2  to  Ind4
showed  94—96%  similarity  to  host-speciﬁc  genotype
A (AF101197.1)  reported  in  humans  with  several
nucleotide changes,  as  shown  in  Table  2.
Nucleotide accession number assigned to
genotypes of E. bieneusi
The  gene  bank  accession  numbers  for  sequences
of genotypes  of  E.  bieneusi  submitted  are
KP325473—KP325476.
Phylogenetic analysis
Fig.  4  shows  the  phylogenetic  tree  view,  which
depicts clustering  of  genotype  Ind1  (1/4)  with
zoonotic genotypes  of  isolates  reported  in  cats
(AF267142.1),  gorillas,  wild  boars,  and  cattle.
Genotypes Ind2  to  Ind4  (3/4)  were  grouped  with
host-speciﬁc  genotypes  of  isolates  reported  in
humans  from  Germany  and  Brazil.Discussion
In the  present  study,  1.8%  of  HIV-infected  patients




ments a deletion as compared to the consensus sequences.
icrosporidia  had  diarrhea  and  drank  unﬁltered
ater. All  four  patients  infected  with  microsporidia
ad a CD4  cell  count  ≤100  cells/l.  All  four
atients were  infected  with  E.  bieneusi.  Four  dis-
inct and  novel  genotypes,  Ind1  to  Ind4,  were
dentiﬁed. Phylogenetic  analysis  of  ITS  sequences
f E.  bieneusi  supports  presumptive  transmission
ainly through  the  anthropological  route  among
IV-infected  patients.  However,  the  zoonotic  route
f transmission  may  also  occur.
Microsporidia  infect  immunocompromised  hosts,
specially  HIV-infected  patients,  worldwide.  In  the
resent study,  1.8%  of  HIV-infected  patients  had
icrosporidia.  Similarly,  a  few  other  studies  from
ndia reported  a prevalence  ranging  from  1%  to
4% based  on  the  microscopic  and  molecular  diag-
ostic methods  employed  [2—5]. However,  from
ther parts  of the  world,  variable  prevalences
rom as  low  as  0.1%  to  as  high  as  50%  have  been
eported depending  on  variations  in  the  study
opulation and  diagnostic  methods  employed  [1].
he low  prevalence  reported  in  the  current  study
ould  be  due  to  empiric  administration  of  anti-
arasitic  drugs  to  the  patient  in  a developing  nation
uch as  India.  In  addition,  administration  of  highly
ctive anti-retroviral  therapy  (HAART)  signiﬁcantly
educes the  risk  of  opportunistic  infection  among
atients  with  HIV  [16].  In  the  current  study,  the
revalence  of  microsporidia  is  comparatively  low
mong HIV-infected  patients.  However,  infection
ith  microsporidia  cannot  be  overlooked  among  HIV
atients, as  it  leads  to  signiﬁcant  morbidity.
In the  current  study,  all  HIV  patients  infected
ith microsporidia  had  diarrhea.  Similarly,  in  a
tudy from  India,  HIV  patients  infected  with
icrosporidia also  presented  with  diarrhea  [5].  In
ddition, other  studies  reported  the  association  of
iarrhea with  microsporidia-infected  HIV-positive
atients from  other  parts  of  the  world  [7,17—20].
hus, these  studies  support  the  association  of
icrosporidia  with  diarrhea  among  HIV-infected
Genotyping  of  Enterocytozoon  bieneusi  among  human  immunodeﬁciency  virus  infected  patients  37












































patients.  In  our  study,  all  four  HIV  patients  infected
with microsporidia  had  a  CD4  count  less  than
100 cells/l.  This  is  in  accordance  with  other  stud-
ies reporting  microsporidia  among  HIV-infected
patients with  low  CD4  counts  [20—24]. There-
fore, HIV-infected  patients  having  a  CD4  cell  count
<100 cells/l  and  presenting  with  diarrhea  should
be tested  for  infection  of  microsporidia.
In our  study,  infection  with  microsporidia  was
more prevalent  in  patients  drinking  unﬁltered
water. Similarly,  in  another  study,  microsporidia
was detected  in  surface  water  [25].  In  a
study from  France,  a  waterborne  outbreak  of
intestinal microsporidiosis  was  reported  in  HIV-
infected  patients  [26]. Therefore,  we  can  spec-
ulate that  contaminated  water  could  be  a
source of  microsporidia  infection  among  HIV-
infected patients.  Therefore,  drinking  ﬁltered
water might  decrease  the  occurrence  of  infection
with microsporidia  among  HIV-infected  patients.
In our  study,  E.  bieneusi  was  identiﬁed  as  the
causative species  in  all  patients  infected  with
microsporidia. This  is  in  accordance  with  previ-
ously  published  reports  worldwide  [2,20,27—30].
Conversely,  in  a  study  from  India,  E.  intestinalis  has
been detected  as  the  most  common  cause  of  infec-
tion among  HIV-infected  patients  with  diarrhea  [5].
E. bieneusi  is  the  most  common  species  infecting
HIV patients  [31]. The  available  drug  of  choice,
albendazole is not  effective  against  E.  bieneusi.
Therefore,  species  differentiation  is  an  important
tool to  administer  appropriate  treatment  therapy
to patients  infected  with  microsporidia.
E. bieneusi  is  the  most  prevalent  species
identiﬁed among  HIV-infected  patients.  However,
no genotypic  studies  on  E.  bieneusi  have  been
documented from  a  developing  nation  such  as
India. Genotyping  would  help  establish  transmis-
sion routes  of  microsporidia  among  humans.  To
the best  of  our  knowledge,  this  is  the  ﬁrst  study
on the  molecular  epidemiology  of  E.  bieneusi  in
HIV-infected  patients  from  India.  In  the  current
study, four  novel  genotypes  of  E.  bieneusi  (Ind1
to Ind4)  were  identiﬁed.  Ind1  showed  95%  simi-
larity to  genotype  L.  Genotype  L  with  zoonotic
potential is  non-host  speciﬁc  and  has  been  identi-
ﬁed in  E.  bieneusi  isolates  reported  in  cats  from
Germany [32].  In  our  study,  genotype  Ind1  was
detected in  a  patient  who  was  in  contact  with
animals. There  are  several  studies  reporting  the
detection  of  microsporidia  in  feces  of  animals,
including dogs,  cats,  cattle,  and  birds  [33,34].
This suggests  possible  transmission  of  spores  from
animals to humans  due  to  infected  animals  shed-
ding spores  of  microsporidia  in  their  feces.  Ind2
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enotype  A  is  host  speciﬁc  and  exclusively  identi-
ed in  humans.  Genotype  A  was  detected  among
IV-infected patients  from  Peru  and  Thailand
15,35].  This  further  suggests  human-to-human
ransmission  of  spores  through  enteric  carriage.
he phylogenetic  tree  constructed  from  ITS
equences of  E.  bieneusi  reported  in  our  study
ligned with  earlier  published  sequences  revealed
he genetic  relatedness  between  them.  Genotype
nd1 from  the  present  study  was  clustered  together
ith genotype  L reported  in  cats  from  Germany.
herefore, Genotype  Ind1  from  humans  is non-
ost speciﬁc,  infecting  both  humans  and  animals.
enotypes  Ind2  to  Ind4  were  clustered  together
ith genotype  A,  which  are  host  speciﬁc,  infect-
ng humans  only.  Therefore,  Ind2  to  Ind4  could
e stated  as  host-speciﬁc  genotypes  following  the
nthroponotic  route  of  transmission.  However,  a
arge number  of  E.  bieneusi-positive  samples  should
e studied  to  establish  its  molecular  epidemiology
n this  geographical  region,  and  further  correlation
ith disease  severity  could  be  performed.
In conclusion,  the  prevalence  of  microsporidia
mong HIV  infected  patients  is 1.8%.  Microsporidia
ommonly causes  diarrhea  among  HIV-infected
atients with  CD4  cell  counts  ≤100  cells/l.  E.
ieneusi  was  the  most  common  species  identi-
ed among  the  studied  HIV-infected  patients.  Four
ovel genotypes  of  E.  bieneusi  were  identiﬁed.
olecular epidemiology  suggested  presumptive
ransmission  of  E.  bieneusi  mainly  through  the
nthropological  route  among  patients  with  HIV.
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